PTC Therapeutics (PTCT) Receives a Buy from Morgan Stanley
In a report released today, Jeffrey Hung from Morgan Stanley maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), with a price ...
Morgan Stanley Remains a Buy on Ultragenyx Pharmaceutical (RARE)
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target ...
Zacks.com on MSN14h
Novartis Rises 5% Since Q4 Earnings: How Should You Play the Stock?
Swiss pharma giant Novartis NVS reported better-than-expected fourth-quarter 2024 results, wherein both earnings and revenues beat estimates. Core earnings (excluding one-time charges) of $1.98 per ...